Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Akumin Inc. Announces Third Quarter 2021 Financial Results


      News provided by

      Akumin Inc.

      Dec 13, 2021, 20:59 ET

      Share this article

      Share this article


      PLANTATION, Fla., Dec. 13, 2021 /PRNewswire/ - Akumin Inc. (NASDAQ: AKU) (TSX: AKU) ("Akumin" or the "Company") announced today its financial results for the quarter ended September 30, 2021 ("Q3 Fiscal 2021").

      Third Quarter 2021 Highlights

      • Akumin completed its acquisition of Alliance HealthCare Services, Inc. ("Alliance") on September 1, 2021, transforming Akumin to the hospital partner of choice in both Radiology and Oncology solutions.
      • The Company operations now span 46 states, serving ~1,000 hospital and healthcare providers, operating over 230 radiology and oncology fixed site locations, with over 2 million procedures and treatments per year on pro forma basis.
      • Akumin delivered strong quarterly same store volume performance on a consolidated, pro forma basis:
        • +8.5% for MRI
        • +2.2% for PET/CT
        • +8.9% for Total Radiology Procedures
        • +10.1% for Oncology Patient Starts
      • The Company reported revenue totaling $108.2 million for the third quarter, a $45.0 million or 71.1% increase over the third quarter of last year. On a sequential basis, revenue increased $38.7 million or 55.7% over second quarter of 2021.
      • Akumin generated $18.0 million of Adjusted EBITDA (as defined below) for the quarter, a $5.8 million or 47.4% increase over the third quarter of last year. On a sequential basis, Adjusted EBITDA increased $5.8 million or 47.1% over second quarter of 2021.
      • Based on our results thus far this year, Akumin is adjusting its 2021 guidance for revenue to range from $421 million to $428 million and for Adjusted EBITDA to range from $65 million to $72 million.

      Note that reported results include Alliance results only from and after September 1, 2021 while when pro forma results are referenced it assumes Alliance was acquired at the beginning of the referenced period.

      Summary Consolidated Financial Results (in thousands, except for per share amounts)



      (Restated)


      (Restated)







      3-month period ended

      Sep. 30, 2021

      3-month period ended

      Sep. 30, 2020

      9-month period ended

      Sep. 30, 2021

      9-month period ended

      Sep. 30, 2020

      MRI Scans

      138

      83

      322

      240

      PET-CT Scans

      11

      2

      14

      4

      Total Scans

      439

      327

      1,137

      904

      Oncology Patient Starts

      1

      -

      1

      -

      Revenue

      108,177

      63,213

      241,636

      178,747

      Adjusted EBITDA (1)

      17,968

      12,191

      39,381

      28,559

      EPS –Diluted

      (0.02)

      (0.10)

      (0.16)

      (0.26)

      (1) See "Non-GAAP Measures" below.

      Commenting on the Q3 Fiscal 2021 financial results, Riadh Zine, Chairman and Co-Chief Executive Officer of the Company, said, "We are pleased with the Q3 results, which incorporate one month of results from the Alliance acquisition.  Our integration synergy initiatives are already underway.  We have also consolidated the financial planning for the combined organization, while advancing the digital transformation of the patient service delivery.  With the increased scale of the company and the depth of the management team, we expect 2022 to be a milestone year as we continue to build on this solid foundation."

      As a result of filing the Q3 Fiscal 2021 financial results, Akumin has now filed all continuous disclosure materials required by applicable Ontario securities laws through to today's date.  As a result, Akumin expects the previously announced Management Cease Trade Order issued by the Ontario Securities Commission on August 20, 2021 will automatically be revoked in accordance with its terms by December 16, 2021, being two full business days after receipt of the filings by the Ontario Securities Commission.

      Unless otherwise indicated, all amounts are expressed in U.S. dollars.  Certain metrics, including those expressed on an adjusted or comparable basis, are non-GAAP measures.  See "Non-GAAP Measures" and "Selected Consolidated Financial Information" of this press release for further details.  The Company's consolidated financial statements for Q3 Fiscal 2021 and related management's discussion and analysis are available in Akumin's public disclosure at www.sedar.com and www.sec.gov.

      Investor Presentation

      Akumin would like to invite interested parties to an investor presentation to be held on Friday, December 17, 2021 from 8:00 a.m. to 9:00 a.m. Eastern Time where management will discuss changes to the Company's business resulting from the closing of the Alliance HealthCare Services acquisition, as well as Q3 Fiscal 2021 results.  To access the conference call, dial toll-free in the U.S. or Canada 888-394-8218 or, for international callers, 647-484-0475. A related presentation will be available from Akumin's public disclosure at www.sedar.com or www.sec.gov and also from Akumin's website (www.akumin.com) and at https://akum.in/InvestorPresentation.  Participants are asked to connect at least 10 minutes prior to the beginning of the call to ensure participation.  The webcast archive will be available for 90 days.  A replay of the presentation will also be available until Friday, December 24, 2021 by calling 647-436-0148 or toll-free 1-888-203-1112, using passcode number 6766278.

      About Akumin

      Akumin is a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service line needs. With the acquisition of Alliance HealthCare Services, Akumin now provides (1) fixed-site outpatient diagnostic imaging services through a network of more than 200 owned and/or operated imaging locations; and (2) outpatient radiology and oncology services and solutions to approximately 1,000 hospitals and health systems across 46 states. By combining clinical and operational expertise with the latest advances in technology and information systems, Akumin and its ~4,000 Team Members facilitate more efficient and effective diagnosis and treatment for patients and their providers in 46 states. Akumin's imaging procedures include MRI, CT, positron emission tomography (PET and PET/CT), ultrasound, diagnostic radiology (X-ray), mammography, and other interventional procedures; our cancer care services include a full suite of radiation therapy and related offerings. For more information, visit www.akumin.com and www.alliancehealthcareservices-us.com.

      Non-GAAP Measures

      This press release refers to certain non-GAAP measures. These non-GAAP measures are not recognized measures under United States generally accepted accounting principles ("GAAP") and do not have a standardized meaning prescribed by GAAP.  There is unlikely to be comparable or similar measures presented by other companies. Rather, these non-GAAP measures are provided as additional information to complement those GAAP measures by providing further understanding of our results of operations from management's perspective. Accordingly, these non-GAAP measures should not be considered in isolation nor as a substitute for analysis of our financial information reported under GAAP. We use non-GAAP financial measures, including "EBITDA", "Adjusted EBITDA" and "Adjusted EBITDA Margin" (each as defined below). These non-GAAP measures are used to provide investors with supplemental measures of our operating performance and thus highlight trends in our core business that may not otherwise be apparent when relying solely on GAAP measures. We believe the use of these non-GAAP measures, along with GAAP financial measures, enhances the reader's understanding of our operating results and is useful to us and to investors in comparing performance with competitors, estimating enterprise value, and making investment decisions.  We also believe that securities analysts, investors, and other interested parties frequently use non-GAAP measures in the evaluation of issuers. Our management uses non-GAAP measures to facilitate operating performance comparisons from period to period, to prepare annual operating budgets and forecasts and to determine components of management compensation. Definitions and reconciliations of non-GAAP measures to the relevant reported measures can be found in our Management's Discussion and Analysis dated December 13, 2021 available in our public disclosure at www.sedar.com and www.sec.gov.

      We define such non-GAAP measures as follows:

      "EBITDA" means net income (loss) before interest expense (net), income tax expense (benefit), and depreciation and amortization.

      "Adjusted EBITDA" means EBITDA, as further adjusted for stock-based compensation, asset impairments, settlement and related costs (recoveries), financial instrument revaluation and related losses (gains), acquisition-related costs, severance and related costs, restructuring charges, other losses (gains), deferred rent expense (credit), and one-time adjustments.

      "Adjusted EBITDA Margin" means Adjusted EBITDA divided by the total revenue in the period.

      Forward-Looking Information

      Certain information in this press release constitutes forward-looking information or forward-looking statements.  In some cases, but not necessarily in all cases, such statements or information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information.  Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates and projections regarding future events.  In particular, this press release contains forward-looking information and statements regarding the expected revocation of the Management Cease Trade Order.

      Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Akumin as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in greater detail in the "Risk Factors" section of our management's discussion and analysis for the quarter ended September 30, 2021 dated December 13, 2021, which is available at www.sedar.com and www.sec.gov. These factors are not intended to represent a complete list of the factors that could affect Akumin; however, these factors should be considered carefully.  There can be no assurance that such estimates and assumptions will prove to be correct.  The forward-looking statements contained in this press release are made as of the date of this press release, and Akumin expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

      Selected Consolidated Financial Information



              (Restated)








      (in thousands)

      Three-month period
      ended
      Sep 30, 2021

      Three-month period
      ended
      Sep 30, 2020

      $ Change

      % Change

      Service fees – net of allowances and discounts

      107,162

      62,675

      44,487

      71%

      Other revenue

      1,015

      538

      477

      89%

      Revenue

      108,177

      63,213

      44,964

      71%






      Employee compensation

      41,779

      21,373

      20,406

      95%

      Reading fees

      10,797

      9,507

      1,290

      14%

      Rent and utilities

      9,507

      7,066

      2,441

      35%

      Third party services and professional fees

      15,928

      7,693

      8,235

      107%

      Administrative

      6,382

      2,631

      3,751

      143%

      Medical supplies and other expenses

      7,103

      2,775

      4,328

      156%

      Depreciation and amortization

      11,286

      4,359

      6,927

      159%

      Stock-based compensation

      785

      568

      217

      38%

      Operational financial instruments revaluation and other (gains) losses

      (68)

      3,630

      (3,698)

      (102%)

      Interest expense

      16,932

      8,961

      7,971

      89%

      Settlement and related costs (recoveries)

      (52)

      1,611

      (1,663)

      (103%)

      Acquisition related costs

      8,784

      174

      8,610

      nmf

      Other financial instruments revaluation and other (gains) losses

      (96)

      (286)

      190

      (66%)

      Income (loss) before income taxes

      (20,890)

      (6,849)

      (14,041)

      205%

      Income tax expense (benefit)

      (22,070)

      (473)

      (21,597)

      nmf

      Non-controlling interest

      2,517

      835

      1,682

      201%

      Net income (loss) attributable to common shareholders

      (1,337)

      (7,211)

      5,874

      (81%)









      (Restated)








      (in thousands)

      Nine-month period
      ended
      Sep 30, 2021

      Nine-month period
      ended
      Sep 30, 2020

      $ Change

      % Change

      Service fees – net of allowances and discounts

      238,872

      176,041

      62,831

      36%

      Other revenue

      2,764

      2,706

      58

      2%

      Revenue

      241,636

      178,747

      62,889

      35%






      Employee compensation

      88,688

      62,072

      26,616

      43%

      Reading fees

      31,642

      27,854

      3,788

      14%

      Rent and utilities

      24,853

      22,884

      1,969

      9%

      Third party services and professional fees

      32,068

      22,914

      9,154

      40%

      Administrative

      14,044

      8,880

      5,164

      58%

      Medical supplies and other expenses

      13,111

      7,984

      5,127

      64%

      Depreciation and amortization

      20,359

      13,001

      7,358

      57%

      Stock-based compensation

      1,997

      1,726

      271

      16%

      Operational financial instruments revaluation and other (gains) losses

      278

      (4,482)

      4,760

      (106%)

      Interest expense

      34,221

      24,437

      9,784

      40%

      Settlement and related costs (recoveries)

      (394)

      2,491

      (2,885)

      (116%)

      Acquisition related costs

      14,412

      474

      13,938

      nmf

      Other financial instruments revaluation and other (gains) losses

      (3,462)

      4,189

      (7,651)

      (183%)

      Income (loss) before income taxes

      (30,181)

      (15,677)

      (14,504)

      93%

      Income tax expense (benefit)

      (21,999)

      498

      (22,497)

      nmf

      Non-controlling interest

      3,388

      1,876

      1,512

      81%

      Net income (loss) attributable to common shareholders

      (11,570)

      (18,051)

      6,481

      (36%)


      Reconciliation of Non-GAAP Measures



      (Restated)


      (Restated)






      (in thousands)

      Three-month period
      ended
      Sep 30, 2021

      Three-month period
      ended
      Sep 30, 2020

      Nine-month period
      ended
      Sep 30, 2021

      Nine-month period
      ended
      Sep 30, 2020

      Net income (loss)

      1,180

      (6,376)

      (8,182)

      (16,175)

      Income tax expense (benefit)

      (22,070)

      (473)

      (21,999)

      498

      Depreciation and amortization

      11,286

      4,359

      20,359

      13,001

      Interest expense

      16,932

      8,961

      34,221

      24,437

      EBITDA

      7,328

      6,471

      24,399

      21,761

      Adjustments:





      Stock-based compensation

      785

      568

      1,997

      1,726

      Settlement and related costs (recoveries)

      (52)

      1,611

      (394)

      2,491

      Acquisition-related costs

      8,784

      174

      14,412

      474

      Financial instrument revaluation and related losses (gains)

      (50)

      2,895

      (3,410)

      (1,178)

      Other losses (gains)

      20

      63

      320

      283

      Severance, restructuring and other charges

      532

      -

      532

      -

      Deferred rent expense(1)

      621

      409

      1,525

      3,002

      Adjusted EBITDA

      17,968

      12,191

      39,381

      28,559

      Revenue

      108,177

      63,213

      241,636

      178,747

      Adjusted EBITDA Margin

      17%

      19%

      16%

      16%

      (1)

      Deferred rent expense is defined as operating lease cost less operating cash flows from operating leases and adjusted for any prepayments or related items.

      SOURCE Akumin Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.